Clinical Trial: Phase I Study to Evaluate the Pharmacokinetics and Safety After Co-administration of L03RD1 and L03RD2 or Administration of CT-L03 in Healthy Volunteers

U.S., Sept. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07158346) titled 'Phase I Study to Evaluate the Pharmacokinetics and Safety After Co-administration of L03RD1 and L03RD2 or Administration of CT-L03 in Healthy Volunteers' on Aug. 28.

Brief Summary: This is a randomized, open, single-dose, crossover-design, phase I study to evaluate the pharmacokinetics and safety after co-administration of L03RD1 and L03RD2 or administration of CT-L03 in healthy volunteers.

Study Start Date: Aug. 18

Study Type: INTERVENTIONAL

Condition: Type 2 Diabetes Mellitus (T2DM)

Intervention: DRUG: L03RD1

1 tablet of L03RD1

DRUG: L03RD2

2 tablets of L03RD2

DRUG: CT-L03

1 tablet of CT-L03

Recruitment Status: RECRUIT...